摘要
血管内皮生长因子受体主要在内皮细胞上表达 ,可介导多种生理效应 ,其体内表达水平受低氧及细胞因子等环境因素调节 ,随着现代分子生物学技术的发展 ,对其结构、功能及两者的关系有了较深入的研究 。
出处
《国外医学(药学分册)》
2001年第1期9-13,共5页
Foreign Medical Sciences(Section of Pharmarcy)
参考文献23
-
1[1]Ergün S, Kilic N, Fiedler W, et al. Vascular endothelial growth factor and its receptor in normal human testicular tissue[J]. Mol Cell Endocrinol, 1997,131(1):9-20.
-
2[2]Gerber HP, Condorelli F, Park J, et al. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes[J]. J Biol Chem, 1997, 272(38):23659 - 23667.
-
3[3]Suzuki H, Seto K, Shinoda Y, et al. Paracrine upregulation of VEGF receptor mRNA in endothelial cells by hypoxia-exposed Hep G2 cells[J]. Am J Physiol, 1999,276(1): G92 - G97.
-
4[4]Brogi E, Schatteman G, Wu T, et al. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression[J]. J Clin Invest, 1996, 97(2):469-476.
-
5[5]Hata Y, Duh E, Zhang K, et al. Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence [ J ]. J Biol Chem, 1998, 273(30): 19294- 19303.
-
6[6]Giraudo E, Primo L, Audero E, et al. Tumor necrosis factor-α regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells [ J]. J Biol Chem, 1998, 273(34) :22128 - 22135.
-
7[7]Patterson C, Perrella MA, Endege WO, et al. Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-α in cultured human vascular endothelial cells [J]. J Clin Invest, 1996, 98(2) :490 - 496.
-
8[8]de Vries C, Escobedo JA, Ueno H, et al. The fms-like tyrosine kinase,a receptor for vascular endothelial growth factor[J]. Science, 1992, 255(5047) :989- 991.
-
9[9]Terman BI, Dougher-Vermazen M, Carrion ME, et al.Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor[J]. Biochem Biophys Res Commun, 1992, 187(3): 1579 - 1586.
-
10[10]Davis-Smyth T, Chen H, Park J, et al. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade[J]. EMBO J, 1996, 15(18):4919 - 4927.
同被引文献44
-
1逄小红,田铧,李跃,张凤鸣,金旭.VEGF-C和受体VEGFR-3mRNA在食管鳞癌中的表达及意义[J].中国肿瘤临床,2005,32(20):1152-1154. 被引量:3
-
2Gille H, Kowalski J, Yu L, et al. A repressor sequene in the juxtamembrance domain of Flt-1(VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3′-kinase activation and endothelial cell migration[J]. EMBO J, 2000, 19(15): 4064-4073.
-
3Nakopoulou L, Stefanaki K, Panayotopoulou E, et al. Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation[J]. Human Pathology, 2002, 33(9): 863-870.
-
4Wu L W, Mayo L D, Dunbar J D, et al. Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation[J]. J Biol Chem, 2000, 275(7): 5096-5103.
-
5Veikkola T, Karkkainen M, Claesson-Welsh L, et al. Regulation of angiogenesis via vascular endothelial growth factor receptors[J]. Cancer Res, 2000, 60(2): 203-212.
-
6Kanno S, Oda N, Abe M, et al. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells[J]. Oncogene, 2000, 19(17): 2138-2146.
-
7Sato Y, Kanno S, Oda N, et al. Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction[J]. Ann N Y Acad Sci, 2000, 902: 201-207.
-
8Bussolati B, Dunk C, Grohman M, et al. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide[J]. Am J Pathol, 2001, 159(3): 993-1008.
-
9Power C, Wang J H, Sookhai S, et al. Bacterial wall products induce downregulation of vascular endothelial growth factor receptors on endothelial cells via a CD14-dependent mechanism: implications for surgical wound healing[J]. J Surg Res, 2001, 101(2): 138-145.
-
10Kampfer H, Pfeilschifter J, Frank S. Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair[J]. Lab Invest, 2001, 81(3): 361-373.?A
引证文献4
-
1明佳,刘旭盛.内皮细胞特异性RTK受体与血管生成[J].第三军医大学学报,2005,27(4):361-363.
-
2李凡,杨为民,叶章群.膀胱癌中缺氧诱导因子-1α的表达和肿瘤血管生成的关系[J].临床泌尿外科杂志,2007,22(4):283-286. 被引量:2
-
3刘浩,林洪生,花宝金,卢雯平.华蟾素调控VEGF/VEGFR-2信号传导抑制肿瘤血管生成的研究[J].中华中医药学刊,2008,26(11):2489-2491. 被引量:22
-
4武彦昭,施惠晶,景尚华,宋军建,赵珍,张兰,单保恩.喉癌组织中VEGF-C及其受体VEGFR-3和D2-40的表达及意义[J].山东医药,2013,53(41):4-7. 被引量:3
二级引证文献27
-
1叶映泉,李庆林,朱耀东,张梅.华蟾素抗肿瘤作用机制研究进展[J].中药药理与临床,2022,38(3):215-221. 被引量:11
-
2李玉梅,陈永强.缺氧诱导因子-1与肿瘤细胞凋亡及血管生成关系的研究进展[J].中华肿瘤防治杂志,2008,15(12):948-950. 被引量:14
-
3周晓红,王玲玲,赵富荣,周怀君.华蟾素对子宫内膜癌HEC-1-B细胞株凋亡和增殖的影响[J].现代生物医学进展,2009,9(14):2625-2627. 被引量:1
-
4杨迪,洒荣桂.中药及提取物抑制肿瘤血管生成抗转移的研究进展[J].吉林中医药,2009,29(12):1104-1106. 被引量:1
-
5李宏良,曾荣香,田华琴,梁贵文,黄小青,陈学彰,王斌.华蟾素联合MPT方案治疗多发性骨髓瘤疗效观察[J].中华全科医学,2010,8(2):169-171. 被引量:6
-
6吴纪霞.抗肿瘤新星蟾蜍毒素的临床应用及其机制的研究进展[J].中国医药指南,2011,9(28):235-237. 被引量:2
-
7李培勇,辛军,伍佰聪,辛明华,吴文峰.HIF-1α、MMP-9、MVD在肾细胞癌中的表达及临床意义[J].重庆医科大学学报,2013,38(2):151-154. 被引量:10
-
8关念波,刘浩,林洪生.肺癌中医药治疗的研究进展及展望[J].临床肿瘤学杂志,2013,18(3):264-267. 被引量:65
-
9刘传波,何佩珊,左明焕.恶性肿瘤外治法的中医认识和新应用[J].中国临床医生杂志,2014,42(6):85-86. 被引量:13
-
10张驰,杜锦朵,赵雷,冉程.RECK、MMP-14及VEGF在喉癌组织中的表达及临床意义[J].陕西医学杂志,2015,44(3):281-283. 被引量:6
-
1史海广,杨学敏,成家军,李志奎.白细胞介素-13可溶性受体对支气管哮喘小鼠嗜酸粒细胞凋亡的影响[J].中华结核和呼吸杂志,2012,35(1):66-68. 被引量:4
-
2李莉,晋红中.与英利昔单抗相关的皮肤不良反应[J].国际皮肤性病学杂志,2010,36(5):258-261.
-
3江德富,王晔华,陈素萍,林竹娟,梁华斌.细菌性肺炎血清可溶性白细胞介素受体(sIL-1RⅠ、sIL-2R、sIL-4R)的测定及其临床意义[J].海峡药学,2011,23(6):66-68. 被引量:2
-
4李元,张治平,吴倩,刘伯英,郭连宏,张洋,吴剑波.白细胞介素1受体新型拮抗剂研究[J].医学研究通讯,2002,31(2):6-9. 被引量:2
-
5刘萍,边强.类风湿性关节炎治疗药Etanercept[J].国外医药(合成药.生化药.制剂分册),2000,21(6):357-358. 被引量:1
-
6初乃惠,朱莉贞,叶志忠,苑松林,王静云,许家琏,马丽萍.重组人白细胞介素-2辅助治疗复治肺结核近期疗效观察[J].中华结核和呼吸杂志,2003,26(9):548-551. 被引量:17
-
7束文慧,江振洲,张陆勇,刘国卿.良性前列腺增生治疗药物对前列腺细胞增殖与凋亡的影响[J].中国生化药物杂志,2004,25(3):184-186.
-
8张艳丽(综述),张娟(综述),王旻(审校).血管内皮生长因子靶向抗肿瘤药物的研究与开发[J].国际肿瘤学杂志,2007,34(4):244-246. 被引量:1
-
9贾慧群,余加林.新生儿肺透明膜病产前使用糖皮质激素的调查[J].儿科药学杂志,2003,9(2):39-41. 被引量:3
-
10李方和,汪由坤,喻植群,赵西平,张俊,杨东亮.外源性IFN α治疗对慢性丙型肝炎患者血清IL 4水平的影响[J].细胞与分子免疫学杂志,1999,15(2):149-150. 被引量:2